Healthcare -
Biotechnology - NASDAQ - US
$ 0.8696
-0.046 %
$ 47.4 M
Market Cap
10.87
P/E
SPRO - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative SPRO - Spero Therapeutics, Inc.
25.6 M
LAST VALUE
-21.72%
2 YEAR CAGR
14.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR